The mean arterial pressure was significantly higher for patients who later developed preeclampsia (1.34 ± 0.24 MoM), while the serum values of PAPP-A, PlGF, and PP-13 were significantly lower for patients who later developed preeclampsia and/or IUGR in comparison with the control group. The gene discussed is PAPPA; the disease is fetal growth restriction.